GlassScriptPhysician profile
John D Lehman
NPI 1275529331
$8,793.09
in general payments reported to CMS, 2019-2025
21 companies · $2,033 in 2025
The $2,033 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,084 · 2020: $738 · 2021: $2,607 · 2022: $285 · 2023: $329 · 2024: $718 · 2025: $2,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615 · Travel and Lodging: $1,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,615.36 |
| Travel and Lodging | $1,463.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $3,360.90 | 2019-2025 | |
| Stryker Corporation | $2,501.00 | 2019-2025 | Aequalis Ascend Flex, Pangea, Conextions Tr Tendon Repair System-Implant Mechanism |
| Arthrex, INC. | $1,984.92 | 2024-2025 | |
| Smith+Nephew, INC. | $173.20 | 2019-2025 | Pico |
| Pacira Pharmaceuticals Incorporated | $121.06 | 2020-2025 | Zilretta, Exparel, Iovera |
| Cumberland Pharmaceuticals, INC. | $113.61 | 2020-2025 | Caldolor |
| Ethicon US, LLC | $95.41 | 2021-2024 | Monocryl, Stratafix, Enseal X1 |
| Ferring Pharmaceuticals INC. | $95.25 | 2020-2025 | Euflexxa |
| Endo Pharmaceuticals INC. | $86.28 | 2020-2023 | Xiaflex |
| Endo USA, INC. | $39.19 | 2024-2025 | Xiaflex |
| Innovation Technologies INC | $33.67 | 2022 | |
| Depuy Synthes Sales INC. | $26.58 | 2022-2024 | Orthovisc, Monovisc |
| Covidien LP | $26.36 | 2019 | |
| Osiris Therapeutics INC. | $25.60 | 2019 | |
| Merck Sharp & Dohme LLC | $25.00 | 2023 | Bridion |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $18.37 | 2019 | |
| Molnlycke Health Care US, LLC | $15.92 | 2025 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Vertex Pharmaceuticals Incorporated | $14.52 | 2025 | |
| Heron Therapeutics, INC. | $13.03 | 2022 | |
| Medline Industries LP | $11.64 | 2019 | |
| Anika Therapeutics, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.